Sierra Oncology, Inc.
SRRADelisted Jul 1, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001290149
Sierra Oncology, Inc. was delisted on Jul 1, 2022; its insiders filed their last Form 4 on Jul 1, 2022; 109 institutions reported holding it in 13F filings for Q2 2022, worth $1.23B in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Sierra Oncology, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
SRRA is no longer listed, so this page shows Q2 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 109
- +35 vs. Q1 2022
- Shares held
- 22.3M
- +1.93M (+9.5%) vs. Q1 2022
- Total value
- $1.23B
- +$573.3M (+87.7%) vs. Q1 2022
- New holders
- 71
- 17 more added
- Sold out
- 36
- 16 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 1 | $4.00K |
| Q2 2022 | 109 | $1.23B |
| Q1 2022 | 75 | $655.0M |
| Q4 2021 | 46 | $267.1M |
| Q3 2021 | 37 | $233.1M |
| Q2 2021 | 34 | $171.8M |
| Q1 2021 | 33 | $149.7M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Sierra Oncology, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 870,636 | $47.9M | 4.52% | −1,471,562−62.8% | Reduced |
| TIG Advisors, LLC | 891,117 | $49.0M | 2.06% | +891,117 | New |
| Magnetar Financial LLC | 1,106,649 | $60.9M | 0.70% | +1,106,649 | New |
| BlackRock Inc. | 1,169,751 | $64.3M | 0.00% | +721,321+160.9% | Added |
| Rock Springs Capital Management LP | 1,174,786 | $64.6M | 1.88% | 00.0% | Unchanged |
| Abingworth LLP | 1,314,127 | $72.3M | 23.14% | +1150.0% | Added |
| Versor Investments LP | 1,579,751 | $86.9M | 3.33% | +1,579,751 | New |
| OrbiMed Advisors LLC | 1,964,770 | $108.0M | 2.10% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,329,509 | $183.1M | 18.38% | −20.0% | Reduced |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −1,062,888−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −572,297−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −443,381−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −425,000−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −325,000−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −284,781−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −217,915−100.0% | Sold out |
| Kynam Capital Management, LP | 0 | $0 | 0.00% | −193,280−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −166,550−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −162,479−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −151,915−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −136,692−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −132,187−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −126,500−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −119,090−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −66,400−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −65,846−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −52,979−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −48,768−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −48,657−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −44,204−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −39,878−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −28,513−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −25,008−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −24,685−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −20,507−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −19,538−100.0% | Sold out |
| Crescent Grove Advisors, LLC | 0 | $0 | 0.00% | −17,786−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −13,906−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −10,321−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −101−100.0% | Sold out |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |